is retatrutide safe for type 1 diabetes Tirzepatide vs. Retatrutide: Key Differences Explained Perceived benefits of treatment for

If retatrutide is licensed by the MHRA in the future, Second Nature plans to assess it as an option alongside our existing Wegovy and Mounjaro programmes

Reduced appetite at the starting dose means you may be eating significantly less without realizing it

In terms of efficacy, the treatment group receiving oral semaglutide achieved statistically significant reductions from baseline in A1C and body weight when compared with placebo

Metabolic markers such as liver enzymes and insulin sensitivity improve

Expected weight change: An additional 3 to 5% of body weight, bringing cumulative loss to approximately 6 to 12%

Tirzepatide is a dual GIP/GLP-1 receptor agonist that generally produces greater weight loss than semaglutide in head-to-head trials